Phase III study of atamestane plus toremifene [Fareston] versus letrozole [Femara] in advanced breast cancer

Trial Profile

Phase III study of atamestane plus toremifene [Fareston] versus letrozole [Femara] in advanced breast cancer

Completed
Phase of Trial: Phase III

Latest Information Update: 04 Aug 2015

At a glance

  • Drugs Atamestane (Primary) ; Letrozole; Toremifene
  • Indications Advanced breast cancer
  • Focus Registrational; Therapeutic Use
  • Sponsors Intarcia Therapeutics
  • Most Recent Events

    • 01 Nov 2007 Final results from this study have been published.
    • 31 Mar 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top